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Introduction: The aim of the study was to assess the effect of complementary supportive therapy (CST) 
on the quality of life and functional capability in patients with heart failure and reduced ejection frac-
tion (HFrEF). 
Patients and Methods: We investigated 33 patients with left ventricular dilatation (LVIDd> 60 mm) 
and reduced ejection fraction (EF <40%) in 76 complementary supportive therapy (CST) periods. Prior 
to each CST period, therapy was optimized (OMT) for one month. CST consists of a 10-day session. In 
addition to OMT, the patients were treated with carnitine, L-arginine, magnesium, thiamine, riboflavin, 
pantothenic acid, niacin, pyridoxal, biotin, lipoic acid, coenzyme Q-10, vitamin E, vitamin C, selenium 
while lying for 30 minutes inside a pulsating electromagnetic field with intensity up to 30 microte-
slas and inhaling negatively ionized oxygen. Before and after each CST period, patients were asked 
to evaluate the quality of life using the Minnesota Living with Heart Failure Questionnaire (MLHFQ) 
and the visual analogue scale and EF, LVIDd and NYHA classes were determined. Statistical analysis 
was based on the t-test, Spearman’s rank correlation coefficient and Wilcoxon’s signed-ranks test. The 
longest observation period was 122 months. 
Results: After administering the complementary supportive therapy, a statistically significant im-
provement (p<0.05) was noticed in the particular items of the MLHFQ, in emotional and physical 
dimensions. The values of VAS and EF increased whereas NYHA and LVIDd decreased significantly 
(p<0.001). 
Conclusion: CST significantly improved the quality of life and functional capacity in patients with 
HFrEF.1,2
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